Varsha Vora
Child & Adolescent Psychiatry · Durham, NCNPI 1851707772
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,826 of the $2,376 with a category attached, or 76.9%. 18 manufacturers reported payments, led by Neos Therapeutics, LP at 34.4% of the total. Reporting peaked in 2019 at $1,924 and has fallen 98.7% since, to $25 in 2025. Among child & adolescent psychiatry clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $23.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neos Therapeutics, LP$817
- Otsuka America Pharmaceutical, Inc.$272
- Alkermes, Inc.$198
- Takeda Pharmaceuticals U.S.A., Inc.$176
- Johnson & Johnson$149
- Sunovion Pharmaceuticals Inc.$132
- plus $632 from 12 others
What the payments were for
- Consulting fees$55023%
- Food & beverage$1,82677%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neos Therapeutics, LP | 13 | $817 |
| Otsuka America Pharmaceutical, Inc. | 14 | $272 |
| Alkermes, Inc. | 10 | $198 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $176 |
| Johnson & Johnson | 4 | $149 |
| Sunovion Pharmaceuticals Inc. | 11 | $132 |
| AbbVie | 9 | $111 |
| Tris Pharma Inc | 6 | $97 |
| Lundbeck LLC | 6 | $93 |
| Corcept Therapeutics | 1 | $78 |
| Ironshore Pharmaceuticals Inc. | 4 | $65 |
| Arbor Pharmaceuticals, Inc. | 3 | $41 |
| Shire North American Group Inc | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Merck | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Adzenys XR-ODT$671
- Cotempla XR-ODT$671
- SPRAVATO$125
How this compares
$2,376 in reported general payments places this provider in the 90th percentile of 91 child & adolescent psychiatry providers in North Carolina.
See all child & adolescent psychiatry providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam ErAlprazolam | 24 | $724 |
| Propranolol Hcl | 11 | $217 |
| Escitalopram Oxalate | 22 | $71 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Durham
- Jennifer ColvinDurham$484
- Daniel GreeneDurham$430
- Kelly SchofieldDurham$198
- Kerry LandryDurham$119
- Joseph CrozierDurham$90
- Steven SutherlandCharlotte$169K
- Shaheda MaroofRaleigh$8K
- Brian WallHillsborough$5K
- Archana KumarGreensboro$4K
- Bradley ReddickCharlotte$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.